Cargando…
A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching
In confirmatory cancer clinical trials, overall survival (OS) is normally a primary endpoint in the intention-to-treat (ITT) analysis under regulatory standards. After the tumor progresses, it is common that patients allocated to the control group switch to the experimental treatment, or another dru...
Autores principales: | Jiménez, José L., Niewczas, Julia, Bore, Alexander, Burman, Carl-Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592474/ https://www.ncbi.nlm.nih.gov/pubmed/34780488 http://dx.doi.org/10.1371/journal.pone.0259178 |
Ejemplares similares
-
Is it time for the weighted log-rank test to play a more important role in confirmatory trials?
por: Su, Zheng, et al.
Publicado: (2017) -
Estimation of treatment effects in weighted log-rank tests
por: Lin, Ray S., et al.
Publicado: (2017) -
Crossing survival curves: alternatives to the log-rank test
por: Bouliotis, George, et al.
Publicado: (2011) -
On the stability of log-rank test under labeling errors
por: Galili, Ben, et al.
Publicado: (2021) -
On the stability of log-rank test under labeling errors
por: Galili, Ben, et al.
Publicado: (2021)